InnoCare Pharma concludes subject enrolment Phase II psorias

The trial aims to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ICP-488 in adult patients.

Related Keywords

China , Chinese , Arrivent Biopharma , Innocare Pharma , Jasmine Cui , , Care Pharma , Clinical Trials Arena ,